Thursday, July 21, 2016 10:36:36 PM
Dexcom management will hold a conference call to discuss the meeting starting at 8:30 a.m. (Eastern Time) on Friday, July 22 2016.
To listen to the conference call, please dial (888) 771-4371 (US/Canada) or (847) 585-4405 (International) and use the confirmation number "430 195 42" approximately five minutes prior to the start time.
The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and then “Events and Webcasts,” and will be archived there for future reference
To listen to the conference call, please dial (888) 771-4371 (US/Canada) or (847) 585-4405 (International) and use the confirmation number "430 195 42" approximately five minutes prior to the start time.
The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and then “Events and Webcasts,” and will be archived there for future reference
Recent DXCM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:35:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:35:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:34:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:34:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:34:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:34:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:34:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:34:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:34:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 09:34:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 09:15:16 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/28/2026 08:10:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:39:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:39:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:39:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:39:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:38:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:18:26 PM
- Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users • Business Wire • 05/26/2026 01:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 09:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:34:28 PM
- Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany • Business Wire • 05/18/2026 11:31:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2026 08:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:39:16 PM
- Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day • Business Wire • 05/14/2026 08:02:00 PM
